COLLAGENEX PHARMACEUTICALS INC 4
4 · COLLAGENEX PHARMACEUTICALS INC · Filed Oct 15, 2003
Insider Transaction Report
Form 4
BROADBENT NANCY C
CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2003-10-14$2.00/sh+6,000$12,000→ 50,875 total - Exercise/Conversion
Options to Purchase Common Stock
2003-10-14−6,000→ 198,000 totalExercise: $2.00Exp: 2006-02-28→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]Includes (a) 47,875 shares of Common Stock held directly by Ms. Broadbent, (b) 2,000 shares of Common Stock held by Ms. Broadbent's spouse and (c) 1,000 shares of Common Stock held by Ms. Broadbent's parent who resides with her.
- [F2]Represents options granted by the Issuer on March 1, 1996 pursuant to its 1992 Stock Option Plan. All 60,000 shares subject to such options became fully vested as of March 1, 2000.
- [F3]Includes multiple option grants with different prices and vesting dates.